Assessing oral malignancies

被引:0
|
作者
Weinberg, MA [1 ]
Estefan, DJ [1 ]
机构
[1] NYU, Coll Dent, Dept Periodont, New York, NY 10010 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Oral cancers account for approximately 3 percent of all cases of cancer in the United States. An estimated 30,000 people will be diagnosed with oral cancer this year, and about one half of them will eventually die of the disease. The most common type of oral cancer is squamous cell carcinoma. Sixty percent of oral cancers are well advanced by the time they are detected, even though physicians and dentists frequently examine the oral cavity. The two most important risk factors for oral cancer are tobacco use and heavy alcohol consumption. The keys to reducing mortality are prevention and control. The earlier any intraoral or extraoral abnormalities or lesions are detected and biopsied, the more lives can be saved. Controversy exists whether screening programs effectively reduce the mortality rate. Specific step-by-step guidelines should be followed to perform an adequate examination of the head and neck. Copyright (C) 2002 American Academy of Family Physicians.
引用
收藏
页码:1379 / 1384
页数:6
相关论文
共 50 条
  • [21] THE ROLE OF THE DENTIST IN THE DETECTION AND DIAGNOSIS OF ORAL MALIGNANCIES
    PATTERSON, WR
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1954, 48 (04): : 421 - 424
  • [22] Assessing the effects of treatments for hematological malignancies on prepubertal growth
    Pearce, MS
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2000, 17 (06) : 441 - 443
  • [23] Assessing the risk of second malignancies after modern radiotherapy
    Wayne D. Newhauser
    Marco Durante
    Nature Reviews Cancer, 2011, 11 : 438 - 448
  • [24] Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies
    Dholakia, Jhalak
    Scalise, Carly
    Arend, Rebecca C.
    CANCERS, 2021, 13 (07)
  • [25] Challenges of Assessing Symptom Burden in Patients with Haematological Malignancies
    Ionova, Tatyana
    Nikitina, Tatyana
    BLOOD, 2016, 128 (22)
  • [26] Assessing the risk of second malignancies after modern radiotherapy
    Newhauser, Wayne D.
    Durante, Marco
    NATURE REVIEWS CANCER, 2011, 11 (06) : 438 - 448
  • [27] Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies
    Espinoza, J. Luis
    Kurokawa, Yu
    Takami, Akiyoshi
    BLOOD REVIEWS, 2019, 33 : 43 - 52
  • [28] Assessing the burden of oral mucositis
    Berger, K.
    Bollig, A.
    Strobach, D.
    Rieger, C.
    Ostermann, H.
    Oncology Research and Treatment, 2015, 38 : 222 - 222
  • [29] Assessing Novel Oral Anticoagulants
    Saljoughian, Manouchehr
    US PHARMACIST, 2018, 43 (02) : 13 - 17